Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Fields, Stanley

The field of the origin of life has progressed very much from the time of Stanley Miller s first experiment. However, the main hypothesis, that cellular life derives from inanimate matter, has not been demonstrated yet. It must then be considered still a working hypothesis. Not that we have alternatives within the realms of science, and I have outlined in Chapter 1 why divine creation cannot be considered as an alternative within science. Of course the question of God is not one that is solved in terms of rationality, but in terms of faith, and we are back to zero. [Pg.268]

Genentech, Inc. was founded in by venture capitalist Robert A. Swanson and biochemist Dr. Heibert W. Boyer. In the early 1970s, Boyer and geneticist Stanley Colien pioneered a new scientific field called recombinant DNA technology. [Pg.212]

Stanley. J l. C L fields, and J R. pills Suiktce Tivaung )... [Pg.764]

Stanley, J.T., Fields, C.L, and J.R. Pitts Sm face Treating with Sunbeams, Advanced Materials Processes, 16 (December 1660)... [Pg.1514]

The problem many chemists have chosen to attack, then, is to find out how proteins are made naturally in cells and then develop methods for replicating those methods in the laboratory. This held of study has now been given the name proteomics. According to a definition suggested by Stanley Fields at the University of Washington, proteomics is the science that seeks to identify and quantify proteins and to determine localization, modifications, interactions, activities, and, ultimately, their functions. Knowledge of this kind is essential, of course, not only in understanding how natural proteins function,... [Pg.181]

Figure 14.5. Energy minimization with Chem3D. Energy minimization of heptapeptide, STANLEY, is carried out with Chem3D using MM2 force field. The inset (Message window) shows the minimization result. Figure 14.5. Energy minimization with Chem3D. Energy minimization of heptapeptide, STANLEY, is carried out with Chem3D using MM2 force field. The inset (Message window) shows the minimization result.
Figure 14.6. Molecular dynamics with Chem3D. Molecular dynamics of heptapeptide, STANLEY, is performed with Chem3D using MM2 force field. The inset shows the following conditions 2.0 fs for step interval, 10 fs for frame interval, 1.0 kcal/atom/ps for heating/ cooling rate, and 300 K as the target temperature. The display is taken midway through the dynamic simulation. Figure 14.6. Molecular dynamics with Chem3D. Molecular dynamics of heptapeptide, STANLEY, is performed with Chem3D using MM2 force field. The inset shows the following conditions 2.0 fs for step interval, 10 fs for frame interval, 1.0 kcal/atom/ps for heating/ cooling rate, and 300 K as the target temperature. The display is taken midway through the dynamic simulation.
Essentially the existence of this enzymatic activity was first established with certainty in the early 1940s in the filtrates of the bacterial organism Cl. perfringens (Cl. welchii) and has been detected subsequently in the filtrates of many other bacteria. Sloane-Stanley (1953) first presented evidence supportive of the presence of a phospholipase C in a mammalian cell, the guinea pig brain. Since that time, momentum in this field of study has increased exponentially with the exciting developments in the signal transduction field. In the latter system, stimulation of a cell leads to activation of a phospholipase C,... [Pg.87]

Williams PS, Moon MH, Giddings JC (1992) Fast separation and characterization of micron size particles by sedimentation/steric field-flow fractionation role of lift forces. In Stanley-Wood NG, Lines RW (eds) Particle size analysis. Royal Society of Chemistry, Cambridge, pp 280-289... [Pg.183]

Krogstad P, Lee S, Johnson G, Stanley K, McNamara J, Moye J, Jackson JB, Aguayo R, Dieudoime A, Khoury M, Mendez H, Nachman S, Wiznia A, BaUow A, Aweeka F, Rosenblatt HM, Perdue L, Frasia A, Jeremy R, Anderson M, Japour A, Fields C, Farnsworth A, Lewis R, Schnittman S, GigUotti M, Maldonaldo S, Lane B, Hernandez JE, et al Pediatric AIDS CUnical Trials Group 377 Study Team. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nehinavir, or ritonavir for pretreated children mfected with human immnnodeficiency virus type 1. Qin imect Dis 2002 34(7) 991-1001. [Pg.2555]

It seems appropriate to dedicate this volume to those friends and experts who had agreed to provide sections for this book, but who died before their sections could be written. There are four of them Ignatius Metil, Walter Szymansky, David W. McDowell, and Stanley Morrow, each an authority in his field, and a wonderful person who will ever remain in the respect and affection of his associates as well as those of his family. [Pg.3]


See other pages where Fields, Stanley is mentioned: [Pg.417]    [Pg.292]    [Pg.311]    [Pg.71]    [Pg.317]    [Pg.34]    [Pg.206]    [Pg.42]    [Pg.49]    [Pg.20]    [Pg.88]    [Pg.108]    [Pg.284]    [Pg.42]    [Pg.34]    [Pg.1662]    [Pg.363]    [Pg.306]    [Pg.132]    [Pg.218]    [Pg.187]    [Pg.213]    [Pg.245]    [Pg.599]    [Pg.121]    [Pg.33]    [Pg.113]    [Pg.335]    [Pg.123]    [Pg.245]    [Pg.213]    [Pg.409]    [Pg.181]    [Pg.297]    [Pg.145]    [Pg.60]    [Pg.3]   
See also in sourсe #XX -- [ Pg.181 ]




SEARCH



Stanley

© 2024 chempedia.info